| 000 | 01905 a2200565 4500 | ||
|---|---|---|---|
| 005 | 20250518012522.0 | ||
| 264 | 0 | _c20190204 | |
| 008 | 201902s 0 0 eng d | ||
| 022 | _a2052-1707 | ||
| 024 | 7 |
_a10.1002/prp2.446 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDonald, Sarah | |
| 245 | 0 | 0 |
_aA comparison of biological activity of commercially available purified native botulinum neurotoxin serotypes A1 to F1 in vitro, ex vivo, and in vivo. _h[electronic resource] |
| 260 |
_bPharmacology research & perspectives _c12 2018 |
||
| 300 |
_ae00446 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBiological Assay _xmethods |
| 650 | 0 | 4 |
_aBody Weight _xdrug effects |
| 650 | 0 | 4 |
_aBotulinum Toxins _xgenetics |
| 650 | 0 | 4 |
_aClostridium botulinum _xgenetics |
| 650 | 0 | 4 |
_aDiaphragm _xinnervation |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aModels, Animal |
| 650 | 0 | 4 |
_aMuscle Relaxation _xdrug effects |
| 650 | 0 | 4 | _aNeurons |
| 650 | 0 | 4 |
_aNeurotoxins _xgenetics |
| 650 | 0 | 4 |
_aPhrenic Nerve _xdrug effects |
| 650 | 0 | 4 | _aPrimary Cell Culture |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 | _aSerogroup |
| 650 | 0 | 4 | _aSpecies Specificity |
| 700 | 1 | _aElliott, Mark | |
| 700 | 1 | _aGray, Bryony | |
| 700 | 1 | _aHornby, Fraser | |
| 700 | 1 | _aLewandowska, Agnieszka | |
| 700 | 1 | _aMarlin, Sandra | |
| 700 | 1 | _aFavre-Guilmard, Christine | |
| 700 | 1 | _aPérier, Cindy | |
| 700 | 1 | _aCornet, Sylvie | |
| 700 | 1 | _aKalinichev, Mikhail | |
| 700 | 1 | _aKrupp, Johannes | |
| 700 | 1 | _aFonfria, Elena | |
| 773 | 0 |
_tPharmacology research & perspectives _gvol. 6 _gno. 6 _gp. e00446 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/prp2.446 _zAvailable from publisher's website |
| 999 |
_c29133071 _d29133071 |
||